黄金城集团

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Immunity-and-Matrix-Regulatory Cells Derived from Human Embryonic Stem Cells Safely and Effectively Treat Mouse Lung Injury and Fibrosis

biorxiv. 2020-04; 
Jun Wu, Dingyun Song, Zhongwen Li, Baojie Guo, Yani Xiao, Wenjing Liu, Lingmin Liang, Chunjing Feng, Tingting Gao, Zai Wang, Jianyan Wen, Shengnan Yang, Peipei Liu, Lei Wang, Yukai Wang, Liang Peng, Guihai Feng, Shiqiang Huang, Glyn Nigel Stacey, Wei Li, Yan Huo, Ronghua Jin, Qi Zhou, Liu Wang, Baoyang Hu, Huaping Dai, Jie Hao
Products/Services Used Details Operation
Cellular Analysis Clinical hESCs were tested weekly for mycoplasma contamination using a Myco-detection Kit (InvivoGen, San Diego, CA, USA; rep-pt1) and endotoxin contamination was tested using a ToxinSensorTM 125 Chromogenic LAL Endotoxin Assay Kit (GenScript, Piscataway, NJ, USA; L00350). Get A Quote

摘要

Lung injury and fibrosis represent the most significant outcomes of severe and acute lung disorders, including COVID-19. However, there are still no effective drugs to treat lung injury and fibrosis. In this study, we report the generation of clinical-grade human embryonic stem cells (hESCs)-derived immunity- and matrix-regulatory cells (IMRCs) manufactured under good manufacturing practice (GMP) requirements, that can treat lung injury and fibrosis in vivo. We generate IMRCs through sequentially differentiating hESCs with xeno-free reagents. IMRCs possess a unique gene expression profile distinct from umbilical cord mesenchymal stem cells (UCMSCs), such as higher levels of proliferative, immunomodulatory and a... More

关键词